The EU’s new data protection law is going to have a great impact on companies worldwide, including those involved in clinical trials. Here’s what you have to know and how to act!
In May 2018, the European Union’s new data protection law, the General Data Protection Regulation (GDPR), is set to replace the current Data Protection Directive (DPD). Although this just sounds like a bunch of complicated words, it will actually have a wide-reaching effect on companies worldwide.
You may read this and wonder why you should care. Well, if your company handles personal data of any sort, then you will likely be affected. One of the sectors hit especially hard by the new changes to the data protection law is the drug development industry. Namely, anyone who is involved in a clinical trial, from sponsors and investigators to CROs and vendors.
Starting in Spring next year,